SCHEMBL7265513

SCHEMBL7265513

BrCc1cc(-c2ccccc2)cc(-c2ccccc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.55
▸ TSHR P16473 2/20 0.55
▸ TRPA1 O75762 1/20 0.55
▸ CYP11B1 P15538 1/20 0.43
▸ CYP11B2 P19099 1/20 0.43
▸ CRHBP P24387 1/20 0.43
▸ CRHR2 Q13324 1/20 0.43
▸ GRIN2D O15399 1/20 0.42
▸ GRIN3B O60391 1/20 0.42
▸ GRIN1 Q05586 1/20 0.42
▸ GRIN2A Q12879 1/20 0.42
▸ GRIN2B Q13224 1/20 0.42
▸ GRIN2C Q14957 1/20 0.42
▸ GRIN3A Q8TCU5 1/20 0.42
▸ AGXT P21549 2/20 0.42
▸ TAAR1 Q96RJ0 2/20 0.41
▸ PPARG P37231 1/20 0.41
▸ PPARD Q03181 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ PTPN1 P18031 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16675050 0.89 TRPA1 (0.54) ALDH1A1TSHRTRPA1CYP11B1CYP11B2
SCHEMBL16675041 0.89 TRPA1 (0.54) ALDH1A1TSHRTRPA1CYP11B1CYP11B2
SCHEMBL3357853 0.86 TRPA1 (0.56) ALDH1A1TSHRTRPA1CYP11B1CYP11B2
SCHEMBL120295 0.83 ALDH1A1 (0.59) ALDH1A1TSHRTRPA1CYP11B1CYP11B2
Biphenyl SCHEMBL7524026 0.81 TSHR (0.82) ALDH1A1TSHRTRPA1AGXTTAAR1
SCHEMBL71123 0.79 ALDH1A1 (0.68) ALDH1A1TSHRTRPA1AGXTTAAR1
SCHEMBL1542350 0.79 ALDH1A1 (0.50) ALDH1A1TSHRCYP11B1CYP11B2CRHBP
SCHEMBL1374017 0.79 ALDH1A1 (0.68) ALDH1A1TSHRTRPA1AGXTTAAR1
Biphenyl SCHEMBL27732862 0.79 ALDH1A1 (0.68) ALDH1A1TSHRTRPA1AGXTTAAR1
SCHEMBL28096322 0.79 ALDH1A1 (0.68) ALDH1A1TSHRTRPA1AGXTTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183191-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-15 — — US disclosed
US-6649284-B2 A blue EL element with high emission efficiency, low operatng voltage; a 9-((R-substituted)n-phenyl)anthracene where the R is t-butyl or aryl or heterocyclic to provide steric hindrance to prevent crystallization; transformers; filters INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2003-11-18 — — US disclosed
US-20020192497-A1 Electroluminance device INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2002-12-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183191-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE CNOT1, NXF1, NR2E1 ALDH1A1 2636/4885TSHR 4154/4885TRPA1 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback